Voxy review

What it is

Voxy is a Scottsdale, Arizona telehealth practice offering four treatments: compounded semaglutide, compounded tirzepatide, injectable NAD⁺ and sermorelin. It publishes a Scottsdale street address and a staffed phone number, and a HIPAA Notice of Privacy Practices. Its compliance page names VialsRX (Houston, Texas) as a licensed compounding pharmacy partner and describes it as 503A, and names Arora Health & Aesthetics, LLC as the medical group, with an explicit disclaimer that inclusion denotes a professional collaboration rather than a joint venture.

How it works

A free assessment with no charge to see whether you qualify, no labs required to start, and care managed by a licensed nurse practitioner who is not named individually — provider details are stated to be available during your consultation. The transparency stack is what distinguishes this practice and it is worth being specific about why: naming both the pharmacy that makes the vial and the medical group that writes the script gives you two independent entities you can look up, which is categorically stronger than a badge that only certifies the website. Very few services on this board name either. Against that sits a compliance gap that is hard to explain away for a company this careful elsewhere. There is no terms of service page at /terms, /terms-of-service, /terms-of-use or /tos — all return not-found — which means no published refund policy, no governing law and no arbitration position, and the only commitment language anywhere is "cancel anytime". The footer claims availability nationwide while the site simultaneously states that services are available only where affiliated providers are licensed and pharmacy partners are authorised to dispense, so the nationwide claim is not a verified state list. No LegitScript certification or pharmacy accreditation seal appears.

Pricing transparency

Complete on one line of the business and absent on the other, which is the whole problem for this board. Voxy publishes a four-tier price ladder for both GLP-1 medications — semaglutide at $179 month-to-month down to $129 on a twelve-month prepay, tirzepatide at $299 down to $199 — with the inclusions listed plainly: medication if prescribed, all injection supplies, free discreet shipping, ongoing check-ins and dose adjustments, messaging with the care team, no hidden fees. That is a genuinely good pricing page. Then sermorelin and injectable NAD⁺ are presented as treatments with descriptive copy and no figure at all, so there is nothing for this board to quote and we quote nothing. Note also that the site's own "starting at $129/mo" headline is the twelve-month prepay tier on the semaglutide line, not a month-to-month rate — a useful signal about how it prices, and a reason to ask specifically whether sermorelin and NAD⁺ carry the same prepay structure before you assume the first number you are quoted is monthly.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are, and the plans page's reference to a 503A licensed pharmacy describes the facility's regulatory category rather than any approval of the preparation. On the evidence, both of the molecules this board cares about are weaker than the marketing around them. Sermorelin is a GHRH analogue that prompts your own pituitary to release growth hormone — the site's own framing, and it is accurate, which is more than most sermorelin copy manages — but the long-term human outcome data behind claims about sleep, lean muscle and recovery remains thin beyond short-term IGF-1 movement. Injected NAD⁺ has no controlled human outcome trials at all; the NAD⁺ forms with human trial data are the oral precursors NR and NMN, and what those trials reliably demonstrate is a raised blood NAD⁺ level rather than the mental clarity, energy and cellular repair the product copy describes. Individual results vary.

Pros and watch-outs

The evidence behind what Voxy prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

How Voxy compares

A few alternatives worth a look, depending on what you’re optimizing for.

• VHVytora Health

  NAD⁺ from a platform that names its pharmacies and its physician group and folds everything into one figure

  See Vytora Health →
• VWVyora Wellness

  NAD⁺ at one flat published monthly price with no membership and no dose-escalation surcharge

  See Vyora Wellness →
• WEWePeptideRx

  NAD⁺ buyers who want milligrams, cadence and supply length stated before they compare a price

  See WePeptideRx →